Integrating High-Resolution Mass Spectral Data, Bioassays and Computational Models to Annotate Bioactives in Botanical Extracts: Case Study Analysis of C. asiatica Extract Associates Dicaffeoylquinic Acids with Protection against Amyloid-β Toxicity

Armando Alcázar Magaña,Ashish Vaswani,Kevin S. Brown,Yuan Jiang,Md Nure Alam,Maya Caruso,Parnian Lak,Paul Cheong,Nora E. Gray,Joseph F. Quinn,Amala Soumyanath,Jan F. Stevens,Claudia S. Maier
DOI: https://doi.org/10.3390/molecules29040838
IF: 4.6
2024-02-14
Molecules
Abstract:Rapid screening of botanical extracts for the discovery of bioactive natural products was performed using a fractionation approach in conjunction with flow-injection high-resolution mass spectrometry for obtaining chemical fingerprints of each fraction, enabling the correlation of the relative abundance of molecular features (representing individual phytochemicals) with the read-outs of bioassays. We applied this strategy for discovering and identifying constituents of Centella asiatica (C. asiatica) that protect against Aβ cytotoxicity in vitro. C. asiatica has been associated with improving mental health and cognitive function, with potential use in Alzheimer's disease. Human neuroblastoma MC65 cells were exposed to subfractions of an aqueous extract of C. asiatica to evaluate the protective benefit derived from these subfractions against amyloid β-cytotoxicity. The % viability score of the cells exposed to each subfraction was used in conjunction with the intensity of the molecular features in two computational models, namely Elastic Net and selectivity ratio, to determine the relationship of the peak intensity of molecular features with % viability. Finally, the correlation of mass spectral features with MC65 protection and their abundance in different sub-fractions were visualized using GNPS molecular networking. Both computational methods unequivocally identified dicaffeoylquinic acids as providing strong protection against Aβ-toxicity in MC65 cells, in agreement with the protective effects observed for these compounds in previous preclinical model studies.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?
This paper aims to solve the problem of how to rapidly screen natural products with biological activity from plant extracts, especially for components that can counteract the toxicity of amyloid - β (Amyloid - β, Aβ) and protect nerve cells from damage. In the study, the Centella asiatica (C. asiatica) extract was used as a case analysis. This plant is known for its ability to improve memory and mental health and is considered to have potential application value in the treatment of Alzheimer's disease. Specifically, the paper annotates the bioactive components in plant extracts by combining high - resolution mass spectrometry data, bioassays, and computational models. The research team used a fractionation method and obtained the chemical fingerprint of each fraction by flow - injection high - resolution mass spectrometry (HRMS), so that the relative abundance of molecular features (representing individual phytochemicals) could be correlated with the results of bioassays. They paid special attention to the components in the C. asiatica extract that could protect MC65 cells (a neuroblastoma cell line) from Aβ toxicity. The main findings of the study are that monocaffeoylquinic acids (MCQAs) and dicaffeoylquinic acids (DCQAs) are closely related to the protective effect against Aβ toxicity, especially showing a significant protective effect in the MC65 cell model. These findings not only verify previous studies on the neuroprotective effects of CQAs in multiple nerve models, but also provide a scientific basis for further exploring the potential of these compounds in preventing or treating neurodegenerative diseases.